GenEdit Competitors and Similar CompaniesClear all
GenEdit's competitors and similar companies include Neurogene, Maze Therapeutics and Cimeio.
 GenEdit GenEdit is a company that develops non-viral delivery technologies for the gene-editing system. |  Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases. |  Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2018 | Founding Date 2018 | Founding Date 2020 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Brisbane, US HQ | Locations New York, US HQ Houston, US | Locations South San Francisco, US HQ Redwood City, US South San Francisco, US | Locations Basel, CH HQ |
Employees | Employees 562% increase | Employees 1091% decrease | Employees 121 | Employees 21 |
Funding | ||||
Latest funding round | Latest funding round $ 8.5m (over 7 years ago) | Latest funding round $ 68.5m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) |
Total funding raised | Total funding raised $ 8.5m | Total funding raised $ 68.5m | Total funding raised $ 191m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Neurogene
HQ
New York, US
Employees
109↓ 1% decrease
Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.
View company
Maze Therapeutics
HQ
South San Francisco, US
Employees
121
Maze Therapeutics is a clinical-stage biopharmaceutical company.
View companyCimeio
HQ
Basel, CH
Employees
21
Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.
View company